SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-072450
Filing Date
2022-06-17
Accepted
2022-06-17 17:07:15
Documents
13
Period of Report
2022-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218648d2_8k.htm   iXBRL 8-K 36846
2 EXHIBIT 10.1 tm2218648d2_ex10-1.htm EX-10.1 138834
  Complete submission text file 0001104659-22-072450.txt   377769

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imgn-20220615.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20220615_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20220615_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2218648d2_8k_htm.xml XML 3464
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 221024892
SIC: 2834 Pharmaceutical Preparations